Previous close | 3.1500 |
Open | 3.1300 |
Bid | 2.9800 x 400 |
Ask | 3.0200 x 300 |
Day's range | 2.9900 - 3.1400 |
52-week range | 2.5700 - 4.1390 |
Volume | |
Avg. volume | 208,377 |
Market cap | 211.423M |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.7400 |
Earnings date | 03 May 2024 - 07 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 7.33 |
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, today announced that management will participate in a virtual presentation at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 9:30 a.m. ET. A live webcast of the Needham presentation can be accessed through the Events & Presentations section of
Last week, Ovid Therapeutics Inc. ( NASDAQ:OVID ) insiders, who had purchased shares in the previous 12 months were...